Before joining Sound Bioventures, Anna worked in pharma business development and external innovation at Novo Nordisk and Johnson & Johnson Innovation, where she spent 10 years in innovation scouting, dealmaking, post-merger integration, and strategic alliances.

Anna also has prior experience from drug launch management, commercial operations, and medical affairs at Johnson & Johnson; and she spent nearly a decade in biomedical research in institutions in Finland and the Netherlands.

Anna holds an MBA from Cambridge University, Judge Business School, a PhD in biochemistry focusing on cancer and inflammation, and an MSc from the University of Helsinki.”

Based in Copenhagen, DK.